Dashboard
Manage Tickers

BDRXBiodexa Pharmaceuticals Plc

Nasdaq midatechpharma.com


$ 1.01 $ 0.02 (2.09 %)    

Wednesday, 17-Jul-2024 13:33:04 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 482.73 $ -5.92 (-1.21 %)
DIA $ 411.71 $ 2.70 (0.66 %)
SPY $ 557.27 $ -1.63 (-0.29 %)
TLT $ 94.21 $ 0.30 (0.32 %)
GLD $ 227.26 $ -1.53 (-0.67 %)
$ 0.9893
$ 0.95
$ 0.00 x 0
$ 1.02 x 200
$ 0.94 - $ 1.01
$ 0.67 - $ 9.64
10,474,141
na
1.18B
$ 1.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

how-is-the-market-feeling-about-biodexa-pharmaceuticals
How Is The Market Feeling About Biodexa Ph...
07/16/2024 18:45:22

biodexa-announces-health-canada-has-approved-phase-2a-dose-confirmation-study-of-tolimidone-in-type-1-diabetes
Biodexa Announces Health Canada Has Approv...
07/16/2024 12:31:35

why-asp-isotopes-shares-are-trading-lower-by-9-here-are-other-stocks-moving-in-fridays-mid-day-session
Why ASP Isotopes Shares Are Trading Lower ...
07/12/2024 17:14:56

why-ericsson-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why Ericsson Shares Are Trading Higher; He...
07/12/2024 09:35:41

gold-rises-sharply-methode-electronics-shares-spike-higher
Gold Rises Sharply; Methode Electronics Sh...
07/11/2024 18:35:05

why-conagra-brands-shares-are-trading-lower-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why ConAgra Brands Shares Are Trading Lowe...
07/11/2024 18:02:49

cancer-focused-nano-cap-biodexa-pharmaceuticals-stock-is-surging-on-thursday---heres-why
Cancer-Focused Nano-Cap Biodexa Pharmaceut...
07/11/2024 16:44:03

Biodexa Pharmaceuticals shares surge following phase 2 trial results for eRapa, a potential treatment for Familial Adenomatous ...

nasdaq-dips-over-300-points-pepsico-reports-weak-sales
Nasdaq Dips Over 300 Points; PepsiCo Repor...
07/11/2024 16:01:20

us-stocks-edge-higher-inflation-slows-to-3-in-june
US Stocks Edge Higher; Inflation Slows To ...
07/11/2024 13:38:23

biodexa-pharmaceuticals-shares-halted-to-the-downside-stock-currently-up-10110
Biodexa Pharmaceuticals Shares Halted To T...
07/11/2024 13:32:43

biodexa-pharmaceuticals-reports-12-month-phase-2-trial-results-for-erapa-in-treating-familial-adenomatous-polyposis
Biodexa Pharmaceuticals Reports 12-Month P...
07/11/2024 12:33:33

17% Median Decrease In Polyp Burden, 75% Non-Progression Rate; Cohort 2 Shows 89% Non-Progressors And 29% Median Polyp Reductio...

biodexa-pharmaceuticals-reports-phase-1-clinical-data-of-mtx110-in-dmg-brain-cancer-demonstrating-increased-survival-presented-at-ispno-2024
Biodexa Pharmaceuticals Reports Phase 1 Cl...
07/02/2024 12:31:05

Biodexa Pharmaceuticals PLCPositive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presen...

biodexa-pharmaceuticals-announces-phase-2-trial-results-of-erapa-in-familial-adenomatous-polyposis-75-non-progression-rate-at-12-months-17-median-decrease-in-polyp-burden-cohort-2-shows-81-non-progression-and-29-median-decrease-informing-phase-3-dosage-results-presented-at-2024-insight-meeting
Biodexa Pharmaceuticals Announces Phase 2 ...
06/24/2024 12:32:10

biodexa-pharmaceuticals-has-been-granted-us-patent-number-12011445-titled-prevention-of-pancreatic-cell-degeneration-for-the-treatment-of-type-i-diabetes-this-patent-is-licensed-from-melior-pharmaceuticals
Biodexa Pharmaceuticals Has Been Granted U...
06/18/2024 14:57:59

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12011445).pn

biodexa-pharmaceuticals-presents-12-month-phase-2-clinical-trial-results-of-erapa-in-familial-adenomatous-polyposis-to-be-presented-at-the-biennial-insight-2024-meeting
Biodexa Pharmaceuticals Presents 12-Month ...
06/10/2024 12:31:48

Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious Bi...

biodexa-pharmaceuticals-highlights-phase-2-data-results-for-erapa
Biodexa Pharmaceuticals Highlights Phase 2...
06/03/2024 12:23:45

After the first six months, eRapa appeared to be safe and well-tolerated with a statistically significant 24% reduction (p=0.04...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/28/2024 20:31:18

nasdaq-falls-over-100-points-tjx-posts-upbeat-q1-results
Nasdaq Falls Over 100 Points; TJX Posts Up...
05/22/2024 18:32:03

why-xp-shares-are-trading-lower-by-around-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why XP Shares Are Trading Lower By Around ...
05/22/2024 17:27:59

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
05/22/2024 16:31:29

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)
07/30/2024 Rivian Automotive, Inc. (RIVN)
07/30/2024 Hertz Global Holdings, Inc. (HTZ)
08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)